Gastroenterites bacterianas: manejo clínico e tratamento
Revista ft · 31.05.2026 · 30 (158) · 01-05
DOI: 10.69849/erz59429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 31.05.2026. Verfasst von Raul Felipe Garcia Silva und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacterial gastroenteritis represents an important cause of morbidity worldwide, affecting children, adults, and the elderly. It is characterized by inflammation of the gastrointestinal tract secondary to bacterial infection, mainly presenting with diarrhea, abdominal pain, fever, and vomiting. The aim of this study is to review the main aspects related to epidemiology, pathophysiology, diagnosis, clinical management, and treatment of bacterial gastroenteritis. This is a narrative review of scientific literature based on national and international articles published in recent years. The results demonstrate that pathogens such as Salmonella spp., Shigella spp., Escherichia coli, Campylobacter jejuni, and Clostridioides difficile are among the main microorganisms involved. Treatment depends on clinical severity, with fluid replacement being the primary therapeutic measure. In selected cases, specific antibiotic therapy may be necessary. It is concluded that early diagnosis and appropriate management are essential for preventing complications and reducing morbidity and mortality.
Zitieren
APA
Silva, R. F. G., & Botelho, L. F. V. (2026). Gastroenterites bacterianas: manejo clínico e tratamento. Revista ft, 30(158), 01-05. https://doi.org/10.69849/erz59429
Vancouver
Silva RFG, Botelho LFV. Gastroenterites bacterianas: manejo clínico e tratamento. Revista ft. 2026;30(158):01-05. doi:10.69849/erz59429
BibTeX
@article{Silva2026,
author = {Silva, Raul Felipe Garcia and Botelho, Luiz Filipe Vieira},
title = {Gastroenterites bacterianas: manejo clínico e tratamento},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {158},
pages = {01--05},
doi = {10.69849/erz59429}
}
EUVIMED